
Rhythm Pharmaceuticals Investor Relations Material
Latest events

Q1 2025
Rhythm Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Rhythm Pharmaceuticals Inc
Access all reports
Rhythm Pharmaceuticals Inc. is a biopharmaceutical company focused on developing treatments for rare genetic disorders related to obesity. The company’s primary area of focus is on conditions caused by impairments in the melanocortin-4 receptor (MC4R) pathway, which regulates hunger and body weight. Rhythm Pharmaceuticals aims to address unmet medical needs by developing targeted therapies that can help manage severe obesity and related symptoms in patients with specific genetic deficiencies. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Rhythm Pharmaceuticals Inc


Q1 2025
Rhythm Pharmaceuticals Inc


Q4 2024
Rhythm Pharmaceuticals Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
RYTM
Country
🇺🇸 United States